FDA approves Eli Lilly’s once-weekly insulin injection for type 2 diabetes
The US Food and Drug Administration has approved Eli Lilly’s once-weekly basal insulin, Onswik, for adults with type 2 diabetes, the drugmaker said on Thursday, offering patients an alternative to daily long-acting insulin injections. Onswik, chemically known as insulin efsitora alfa-gobe, is intended to be used alongside diet and exercise to control high blood sugar. … Read more